bisoprolol has been researched along with Long QT Syndrome in 7 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We describe two cases where a switch to bisoprolol resulted in worsening of arrhythmia control: A man with LQT2, asymptomatic on propranolol, experienced syncope after switching to bisoprolol 5 mg daily." | 7.83 | Two Cases of LQT Syndrome with Malignant Syncope after Switch from Propranolol to Bisoprolol. ( Jensen, SM; Kesek, M; Rydberg, A, 2016) |
| " We describe two cases where a switch to bisoprolol resulted in worsening of arrhythmia control: A man with LQT2, asymptomatic on propranolol, experienced syncope after switching to bisoprolol 5 mg daily." | 3.83 | Two Cases of LQT Syndrome with Malignant Syncope after Switch from Propranolol to Bisoprolol. ( Jensen, SM; Kesek, M; Rydberg, A, 2016) |
| "Bisoprolol treatment results in QTc shortening in gene-positive LQT1 and LQT2 patients and is well tolerated during long-term administration." | 1.43 | Experience with bisoprolol in long-QT1 and long-QT2 syndrome. ( Adler, A; Al-Sabeq, B; Andrade, JG; Bennett, MT; Chakrabarti, S; Deyell, MW; Green, M; Kerr, CR; Klein, GJ; Krahn, AD; Laksman, ZW; Padfield, GJ; Steinberg, C; Yee, R; Yeung-Lai-Wah, JA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higa, A | 1 |
| Hoshi, H | 1 |
| Yanagisawa, Y | 1 |
| Ito, E | 1 |
| Morisawa, G | 1 |
| Imai, JI | 1 |
| Watanabe, S | 1 |
| Takagi, M | 1 |
| Fazio, G | 1 |
| Vernuccio, F | 1 |
| Lo Re, G | 1 |
| Grutta, G | 1 |
| Mongiovì, M | 1 |
| Kesek, M | 1 |
| Rydberg, A | 1 |
| Jensen, SM | 1 |
| Steinberg, C | 1 |
| Padfield, GJ | 1 |
| Al-Sabeq, B | 1 |
| Adler, A | 1 |
| Yeung-Lai-Wah, JA | 1 |
| Kerr, CR | 1 |
| Deyell, MW | 1 |
| Andrade, JG | 1 |
| Bennett, MT | 1 |
| Yee, R | 1 |
| Klein, GJ | 1 |
| Green, M | 1 |
| Laksman, ZW | 1 |
| Krahn, AD | 1 |
| Chakrabarti, S | 1 |
| Kuusela, J | 1 |
| Kim, J | 1 |
| Räsänen, E | 1 |
| Aalto-Setälä, K | 1 |
| Yoshiga, Y | 1 |
| Shimizu, A | 1 |
| Yamagata, T | 1 |
| Hayano, T | 1 |
| Ueyama, T | 1 |
| Ohmura, M | 1 |
| Itagaki, K | 1 |
| Kimura, M | 1 |
| Matsuzaki, M | 1 |
| Dubrey, SW | 1 |
| Grocott-Mason, R | 1 |
1 trial available for bisoprolol and Long QT Syndrome
| Article | Year |
|---|---|
Beta-blocker decreases the increase in QT dispersion and transmural dispersion of repolarization induced by bepridil.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Bisoprolol | 2002 |
6 other studies available for bisoprolol and Long QT Syndrome
| Article | Year |
|---|---|
Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis.
Topics: Amlodipine; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Cardiotoxicity; Ce | 2017 |
Role of bisoprolol in patients with long QT syndrome.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Child; Electrocardiography; E | 2013 |
Two Cases of LQT Syndrome with Malignant Syncope after Switch from Propranolol to Bisoprolol.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Bisoprolol; Drug Administration Schedule; Humans; L | 2016 |
Experience with bisoprolol in long-QT1 and long-QT2 syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Canada; Cardiotonic Agents; Cohort Studie | 2016 |
The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Cells, Cultured; Dose-Response Relationsh | 2016 |
Drug-induced QT prolongation: consequences and current dilemma.
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Bisoprolol; Electrocardiography; Female; Humans; Long QT | 2007 |